Cerity Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.28M Sell
13,858
-2,162
-13% -$1.14M 0.01% 657
2025
Q1
$10.2M Sell
16,020
-40
-0.2% -$25.4K 0.02% 481
2024
Q4
$12.6M Buy
16,060
+512
+3% +$401K 0.03% 423
2024
Q3
$16.3M Buy
15,548
+2,423
+18% +$2.55M 0.04% 361
2024
Q2
$13.8M Sell
13,125
-1,819
-12% -$1.91M 0.04% 343
2024
Q1
$14.4M Buy
14,944
+3,486
+30% +$3.36M 0.04% 362
2023
Q4
$10.1M Buy
11,458
+7,897
+222% +$6.94M 0.03% 369
2023
Q3
$2.93M Sell
3,561
-5,890
-62% -$4.85M 0.01% 506
2023
Q2
$6.79M Buy
9,451
+200
+2% +$144K 0.03% 436
2023
Q1
$8.32M Buy
9,251
+44
+0.5% +$39.6K 0.02% 382
2022
Q4
$6.64M Buy
9,207
+363
+4% +$262K 0.04% 317
2022
Q3
$6.09M Buy
8,844
+28
+0.3% +$19.3K 0.07% 210
2022
Q2
$5.21M Buy
8,816
+2,579
+41% +$1.52M 0.06% 243
2022
Q1
$4.36M Sell
6,237
-2,789
-31% -$1.95M 0.07% 210
2021
Q4
$5.7M Buy
9,026
+3,221
+55% +$2.04M 0.09% 183
2021
Q3
$3.51M Sell
5,805
-34
-0.6% -$20.6K 0.08% 193
2021
Q2
$3.26M Buy
5,839
+157
+3% +$87.7K 0.07% 204
2021
Q1
$2.69M Buy
5,682
+11
+0.2% +$5.2K 0.06% 217
2020
Q4
$2.74M Buy
5,671
+609
+12% +$294K 0.09% 174
2020
Q3
$2.83M Buy
5,062
+249
+5% +$139K 0.12% 138
2020
Q2
$3M Buy
4,813
+206
+4% +$128K 0.17% 112
2020
Q1
$2.25M Buy
4,607
+508
+12% +$248K 0.14% 127
2019
Q4
$1.54M Sell
4,099
-620
-13% -$233K 0.08% 189
2019
Q3
$1.31M Buy
4,719
+85
+2% +$23.6K 0.08% 215
2019
Q2
$1.45M Buy
4,634
+85
+2% +$26.6K 0.09% 189
2019
Q1
$1.87M Sell
4,549
-285
-6% -$117K 0.13% 172
2018
Q4
$1.81M Buy
4,834
+90
+2% +$33.6K 0.12% 165
2018
Q3
$1.92M Buy
4,744
+157
+3% +$63.4K 0.13% 170
2018
Q2
$1.58M Buy
4,587
+115
+3% +$39.7K 0.12% 184
2018
Q1
$1.54M Sell
4,472
-254
-5% -$87.5K 0.12% 177
2017
Q4
$1.78M Sell
4,726
-1,614
-25% -$607K 0.12% 171
2017
Q3
$2.84M Buy
+6,340
New +$2.84M 0.2% 112
2017
Q2
Sell
-4,887
Closed -$1.89M 420
2017
Q1
$1.89M Buy
+4,887
New +$1.89M 0.16% 127